IDSA GUIDELINES Bundle (free trial)

Catheter-Associated Bacteriuria

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/53990

Contents of this Issue

Navigation

Page 8 of 9

> If the catheter can be discontinued, a voided midstream urine culture should be obtained prior to the initiation of antimicrobial therapy to help guide treatment (A-III). Duration of Treatment ÎSeven days is the recommended duration of antimicrobial treatment for patients with CA-UTI who have prompt resolution of symptoms (A-III), and 10 to 14 days is recommended in those with a delayed response (A-III), regardless of whether the patient remains catheterized or not. > A 5-day regimen of levofloxacin may be considered in patients with CA-UTI who are not severely ill (B-III). Data are insufficient to make such a recommendation about other fluoroquinolones. > A 3-day antimicrobial regimen may be considered for women age 65 or younger who develop CA-UTI without upper tract symptoms after an indwelling catheter has been removed (B-II). Consider condom (in men), intermittent and suprapubic catheterization as alternates If urethral catheter is indicated: Aseptic technique is more important in institutional than in community settings Maintain integrity of closed system Remove as soon as possible If ASB in women ≥ 48 hours aſter removal Consider treatment If UTI Replace catheter aſter 2 weeks if still needed If ASB Treatment not indicated Obtain C&S from new catheter or voided midstream specimen Treat for 7-14 days (Consider 5 days of levof loxacin) Consider 3 days for women ≤ 65 without upper tract symptoms) 7 Urinary Catheters Careful screening:

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Catheter-Associated Bacteriuria